Document Detail


Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.
MedLine Citation:
PMID:  21057159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND & AIM: Non alcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. Population studies have demonstrated that men and posmenopausal women have higher prevalence of NAFLD. The aim was to investigate the prevalence of NAFLD in premenopausal, posmenopausal and polycystic ovary syndrome (PCOS) women.
METHODS: A cross sectional study carried out at University Hospital in Mexico City from January 2009 to November 2009. One hundred ninety seven women who agreed to participate were divided into groups, comprising 93 with NAFLD and without NAFLD. Anthropometric, metabolic and biochemical variables were measured. Serum estradiol and cortisol concentrations were determined and compared between the groups.
RESULTS: Of the 197 patients, 93(47.2%) had NAFLD and 104 (52.8%) did not have NAFLD. The prevalence of NAFLD in premenopausal, postmenopausal and PCOS patients was 32.2, 57.9, and 62%, respectively. Age, BMI, hip to waist ratio, fasting glucose, HOMA -IR, and insulin were significantly higher in NAFLD patients. Women without NAFLD had significantly higher levels of serum estradiol (100 ± 95.4) compared with NAFLD patients (55.5 ± 66.6) p = 0.001. By group with and without NAFLD: premenopausal (55.44±93.3 vs. 128.56 ± 109.22), posmenopausal (44.98 ± 51.41 vs. 42.72 ± 51.48) and PCOS women (64.9 ± 53.3 vs. 101.36 ± 80.89) had significantly different hormone profile.
CONCLUSION: These results suggest that NAFLD is more prevalent in postmenopausal and women with PCOS than those premenopausal ones. The estrogens may have a protective effect of against NAFLD in women.
Authors:
Ylse Gutierrez-Grobe; Guadalupe Ponciano-Rodríguez; Martha H Ramos; Misael Uribe; Nahum Méndez-Sánchez
Related Documents :
22448649 - Prostate-specific antigen testing in older men in the usa: data from the behavioral ris...
3115839 - Elevated levels of ca-125 in serum of patients suffering from ovarian hyperstimulation ...
16793959 - Oxidised low-density lipoprotein concentration - early marker of an altered lipid metab...
7633169 - Selection of ovarian stimulation protocol is related to ivf treatment outcome in women ...
24187469 - Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
12544499 - Update on granulosa cell tumours of the ovary.
8943089 - What can progress in reproductive technology mean for women?
16882679 - Electrocardiographic risk stratification in families with congenital long qt syndrome.
1314239 - Fat distribution in european men: a comparison of anthropometric measurements in relati...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of hepatology     Volume:  9     ISSN:  1665-2681     ISO Abbreviation:  Ann Hepatol     Publication Date:    2010 Oct-Dec
Date Detail:
Created Date:  2010-11-08     Completed Date:  2011-02-17     Revised Date:  2013-05-16    
Medline Journal Info:
Nlm Unique ID:  101155885     Medline TA:  Ann Hepatol     Country:  Mexico    
Other Details:
Languages:  eng     Pagination:  402-9     Citation Subset:  IM    
Affiliation:
Medica Sur Clinic and Foundation, Mexico City, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cross-Sectional Studies
Estrogens / physiology*
Fatty Liver / epidemiology,  etiology,  physiopathology
Female
Humans
Middle Aged
Polycystic Ovary Syndrome / complications,  physiopathology*
Postmenopause / physiology*
Premenopause / physiology*
Prevalence
Risk Factors
Chemical
Reg. No./Substance:
0/Estrogens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence and factors associated with the presence of abnormal function liver tests in patients wit...
Next Document:  Synergistic effect of celecoxib on 5-fluorouracil-induced apoptosis in hepatocellular carcinoma pati...